메뉴 건너뛰기




Volumn 8, Issue 12, 2010, Pages 1388-1416

Cervical cancer: Clinical practice guidelines in oncology

(24)  Greer, Benjamin E a   Koh, Wui Jin a   Abu Rustum, Nadeem R b   Apte, Sachin M c   Campos, Susana M d   Chan, John e   Cho, Kathleen R f   Copeland, Larry g   Crispens, Marta Ann h   DuPont, Nefertiti i   Eifel, Patricia J j   Gaffney, David K k   Huh, Warner K l   Kapp, Daniel S m   Lurain III, John R n   Martin, Lainie n   Morgan, Mark A o   Morgan Jr , Robert J p   Mutch, David q   Remmenga, Steven W r   more..


Author keywords

Cervical cancer; Chemotherapy; Human papillomavirus; Hysterectomy; NCCN clinical practice guidelines; NCCN guidelines; Radiation therapy

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN; NAVELBINE; PACLITAXEL; PEMETREXED; TOPOTECAN;

EID: 78951471907     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0104     Document Type: Review
Times cited : (65)

References (168)
  • 2
    • 68449103669 scopus 로고    scopus 로고
    • Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity
    • Barnholtz-Sloan J, Patel N, Rollison D, et al. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control 2009;20:1129-1138.
    • (2009) Cancer Causes Control , vol.20 , pp. 1129-1138
    • Barnholtz-Sloan, J.1    Patel, N.2    Rollison, D.3
  • 3
    • 76249111835 scopus 로고    scopus 로고
    • Cervical cancer incidence among 6 asian ethnic groups in the United States, 1996 through 2004
    • Wang SS, Carreon JD, Gomez SL, Devesa SS. Cervical cancer incidence among 6 asian ethnic groups in the United States, 1996 through 2004. Cancer 2010;116:949-956.
    • (2010) Cancer , vol.116 , pp. 949-956
    • Wang, S.S.1    Carreon, J.D.2    Gomez, S.L.3    Devesa, S.S.4
  • 4
    • 33750053863 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations
    • Howe HL, Wu X, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
    • (2006) Cancer , vol.107 , pp. 1711-1742
    • Howe, H.L.1    Wu, X.2    Ries, L.A.G.3
  • 5
    • 14744280487 scopus 로고    scopus 로고
    • Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival
    • Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 2005;103:1258-1264.
    • (2005) Cancer , vol.103 , pp. 1258-1264
    • Sherman, M.E.1    Wang, S.S.2    Carreon, J.3    Devesa, S.S.4
  • 7
    • 33646568784 scopus 로고    scopus 로고
    • Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
    • Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150.
    • (2006) J Clin Oncol , vol.24 , pp. 2137-2150
    • Kamangar, F.1    Dores, G.M.2    Anderson, W.F.3
  • 8
    • 20944448032 scopus 로고    scopus 로고
    • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial
    • Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-278.
    • (2005) Lancet Oncol , vol.6 , pp. 271-278
    • Villa, L.L.1    Costa, R.L.2    Petta, C.A.3
  • 9
    • 34249654115 scopus 로고    scopus 로고
    • Effect of prophylactic human papillomavirus L1 virus-like- Particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials
    • Ault KA. Effect of prophylactic human papillomavirus L1 virus-like- particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-1868.
    • (2007) Lancet , vol.369 , pp. 1861-1868
    • Ault, K.A.1
  • 10
    • 34248326338 scopus 로고    scopus 로고
    • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
    • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-1927.
    • (2007) N Engl J Med , vol.356 , pp. 1915-1927
  • 11
    • 33847013679 scopus 로고    scopus 로고
    • Review of current knowledge on HPV vaccination: An appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening
    • Arbyn M, Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol 2007;38:189-197.
    • (2007) J Clin Virol , vol.38 , pp. 189-197
    • Arbyn, M.1    Dillner, J.2
  • 12
    • 34548451979 scopus 로고    scopus 로고
    • Prophylactic vaccination against human papillomavirus infection and disease in women: A systematic review of randomized controlled trials
    • DOI 10.1503/cmaj.070948
    • Rambout L, Hopkins L, Hutton B, Fergusson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 2007;177:469-479. (Pubitemid 47359770)
    • (2007) Canadian Medical Association Journal , vol.177 , Issue.5 , pp. 469-479
    • Rambout, L.1    Hopkins, L.2    Hutton, B.3    Fergusson, D.4
  • 13
    • 33846622321 scopus 로고    scopus 로고
    • Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
    • Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-891.
    • (2007) Int J Cancer , vol.120 , pp. 885-891
  • 14
    • 16844368575 scopus 로고    scopus 로고
    • Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening
    • Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-686.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 677-686
    • Bray, F.1    Loos, A.H.2    McCarron, P.3
  • 15
    • 56449098420 scopus 로고    scopus 로고
    • Burden of cervical cancer in the United States, 1998-2003
    • Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008;113:2855-2864.
    • (2008) Cancer , vol.113 , pp. 2855-2864
    • Watson, M.1    Saraiya, M.2    Benard, V.3
  • 16
    • 27744513901 scopus 로고    scopus 로고
    • Incidence trends of adenocarcinoma of the cervix in 13 European countries
    • Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-2199.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 2191-2199
    • Bray, F.1    Carstensen, B.2    Moller, H.3
  • 17
    • 1242287067 scopus 로고    scopus 로고
    • Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000
    • Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044.
    • (2004) Cancer , vol.100 , pp. 1035-1044
    • Wang, S.S.1    Sherman, M.E.2    Hildesheim, A.3
  • 18
    • 33644764973 scopus 로고    scopus 로고
    • Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention
    • Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006;98:303-315.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 303-315
    • Castellsague, X.1    Diaz, M.2    De Sanjose, S.3
  • 19
    • 67650083308 scopus 로고    scopus 로고
    • Screening and adenocarcinoma of the cervix
    • Sasieni P, Castanon A, Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009;125:525-529.
    • (2009) Int J Cancer , vol.125 , pp. 525-529
    • Sasieni, P.1    Castanon, A.2    Cuzick, J.3
  • 20
    • 77956992491 scopus 로고    scopus 로고
    • Prospective study of human papillomavirus and risk of cervical adenocarcinoma
    • Dahlstrom LA, Ylitalo N, Sundstrom K, et al. Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer 2010;127:1923-1930.
    • (2010) Int J Cancer , vol.127 , pp. 1923-1930
    • Dahlstrom, L.A.1    Ylitalo, N.2    Sundstrom, K.3
  • 21
    • 0036635058 scopus 로고    scopus 로고
    • ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002
    • American College of Obstetricians and Gynecologists
    • ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;78:79-91.
    • (2002) Int J Gynaecol Obstet , vol.78 , pp. 79-91
  • 22
    • 42449086795 scopus 로고    scopus 로고
    • Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: A gynecologic oncology group study
    • DOI 10.1002/cncr.23400
    • Gold MA, Tian C, Whitney CW, et al. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Cancer 2008;112:1954-1963. (Pubitemid 351574071)
    • (2008) Cancer , vol.112 , Issue.9 , pp. 1954-1963
    • Gold, M.A.1    Tian, C.2    Whitney, C.W.3    Rose, P.G.4    Lanciano, R.5    Mackey, D.6
  • 23
    • 34247189183 scopus 로고    scopus 로고
    • Which clinical/ pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials
    • Monk BJ, Tian C, Rose PG, Lanciano R. Which clinical/ pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 2007;105:427-433.
    • (2007) Gynecol Oncol , vol.105 , pp. 427-433
    • Monk, B.J.1    Tian, C.2    Rose, P.G.3    Lanciano, R.4
  • 24
    • 33746002322 scopus 로고    scopus 로고
    • Total laparoscopic radical hysterectomy and lymphadenectomy: The M. D. Anderson Cancer Center experience
    • Ramirez PT, Slomovitz BM, Soliman PT, et al. Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience. Gynecol Oncol 2006;102:252-255.
    • (2006) Gynecol Oncol , vol.102 , pp. 252-255
    • Ramirez, P.T.1    Slomovitz, B.M.2    Soliman, P.T.3
  • 25
    • 0242352420 scopus 로고    scopus 로고
    • Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: Pilot data and comparison to laparotomy
    • Abu-Rustum NR, Gemignani ML, Moore K, et al. Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy. Gynecol Oncol 2003;91:402-409.
    • (2003) Gynecol Oncol , vol.91 , pp. 402-409
    • Abu-Rustum, N.R.1    Gemignani, M.L.2    Moore, K.3
  • 26
    • 0033142407 scopus 로고    scopus 로고
    • Laparoscopy in gynecologic malignancies
    • Williston Park
    • Chi DS. Laparoscopy in gynecologic malignancies. Oncology (Williston Park) 1999;13:773-782.
    • (1999) Oncology , vol.13 , pp. 773-782
    • Chi, D.S.1
  • 27
    • 51649109578 scopus 로고    scopus 로고
    • The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: A prospective analysis of 295 patients
    • Chen Y, Xu H, Li Y, et al. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients. Ann Surg Oncol 2008;15:2847-2855.
    • (2008) Ann Surg Oncol , vol.15 , pp. 2847-2855
    • Chen, Y.1    Xu, H.2    Li, Y.3
  • 28
    • 35548934991 scopus 로고    scopus 로고
    • Laparoscopic total radical hysterectomy by the Pune technique: Our experience of 248 cases
    • Puntambekar SP, Palep RJ, Puntambekar SS, et al. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol 2007;14:682-689.
    • (2007) J Minim Invasive Gynecol , vol.14 , pp. 682-689
    • Puntambekar, S.P.1    Palep, R.J.2    Puntambekar, S.S.3
  • 29
    • 64149095586 scopus 로고    scopus 로고
    • A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer
    • Lowe MP, Chamberlain DH, Kamelle SA, et al. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer. Gynecol Oncol 2009;113:191-194.
    • (2009) Gynecol Oncol , vol.113 , pp. 191-194
    • Lowe, M.P.1    Chamberlain, D.H.2    Kamelle, S.A.3
  • 30
    • 58149402753 scopus 로고    scopus 로고
    • Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer
    • Nezhat FR, Datta MS, Liu C, et al. Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer. JSLS 2008;12:227-237.
    • (2008) JSLS , vol.12 , pp. 227-237
    • Nezhat, F.R.1    Datta, M.S.2    Liu, C.3
  • 31
    • 77950286060 scopus 로고    scopus 로고
    • Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: A 3-year experience
    • Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Gynecol Oncol 2010;117:260-265.
    • (2010) Gynecol Oncol , vol.117 , pp. 260-265
    • Cantrell, L.A.1    Mendivil, A.2    Gehrig, P.A.3    Boggess, J.F.4
  • 33
    • 42449105249 scopus 로고    scopus 로고
    • Surgical staging and cervical cancer: After 30 years, have we reached a conclusion?
    • Moore DH. Surgical staging and cervical cancer: after 30 years, have we reached a conclusion? Cancer 2008;112:1874-1876.
    • (2008) Cancer , vol.112 , pp. 1874-1876
    • Moore, D.H.1
  • 34
    • 64049094855 scopus 로고    scopus 로고
    • Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
    • Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-104.
    • (2009) Int J Gynaecol Obstet , vol.105 , pp. 103-104
    • Pecorelli, S.1
  • 36
    • 39249084861 scopus 로고    scopus 로고
    • Comparison of the validity of magnetic resonance imaging and positron emission tomography/ computed tomography in the preoperative evaluation of patients with uterine corpus cancer
    • Park JY, Kim EN, Kim DY, et al. Comparison of the validity of magnetic resonance imaging and positron emission tomography/ computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 2008;108:486-492.
    • (2008) Gynecol Oncol , vol.108 , pp. 486-492
    • Park, J.Y.1    Kim, E.N.2    Kim, D.Y.3
  • 37
    • 45149106621 scopus 로고    scopus 로고
    • Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area
    • Boughanim M, Leboulleux S, Rey A, et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008;26:2558-2561.
    • (2008) J Clin Oncol , vol.26 , pp. 2558-2561
    • Boughanim, M.1    Leboulleux, S.2    Rey, A.3
  • 38
    • 77950896763 scopus 로고    scopus 로고
    • Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix
    • CD006248.
    • Baalbergen A, Veenstra Y, Stalpers LL, Ansink AC. Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev 2010:CD006248.
    • (2010) Cochrane Database Syst Rev
    • Baalbergen, A.1    Veenstra, Y.2    Stalpers, L.L.3    Ansink, A.C.4
  • 39
    • 77953280110 scopus 로고    scopus 로고
    • Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix
    • Park JY, Kim DY, Kim JH, et al. Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer 2010;102:1692-1698.
    • (2010) Br J Cancer , vol.102 , pp. 1692-1698
    • Park, J.Y.1    Kim, D.Y.2    Kim, J.H.3
  • 40
    • 0030875607 scopus 로고    scopus 로고
    • Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
    • Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-540.
    • (1997) Lancet , vol.350 , pp. 535-540
    • Landoni, F.1    Maneo, A.2    Colombo, A.3
  • 41
    • 0033561259 scopus 로고    scopus 로고
    • Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
    • Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
    • (1999) N Engl J Med , vol.340 , pp. 1154-1161
    • Keys, H.M.1    Bundy, B.N.2    Stehman, F.B.3
  • 43
    • 0033993937 scopus 로고    scopus 로고
    • Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
    • Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
    • (2000) J Clin Oncol , vol.18 , pp. 1606-1613
    • Peters, W.A.1    Liu, P.Y.2    Barrett, R.J.3
  • 44
    • 0032895783 scopus 로고    scopus 로고
    • Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
    • Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
    • (1999) J Clin Oncol , vol.17 , pp. 1339-1348
    • Whitney, C.W.1    Sause, W.2    Bundy, B.N.3
  • 45
    • 0033561333 scopus 로고    scopus 로고
    • Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
    • Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
    • (1999) N Engl J Med , vol.340 , pp. 1144-1153
    • Rose, P.G.1    Bundy, B.N.2    Watkins, E.B.3
  • 46
    • 0033560677 scopus 로고    scopus 로고
    • Improved treatment for cervical cancer - Concurrent chemotherapy and radiotherapy
    • Thomas GM. Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy. N Engl J Med 1999;340:1198-1200.
    • (1999) N Engl J Med , vol.340 , pp. 1198-1200
    • Thomas, G.M.1
  • 47
    • 34447562948 scopus 로고    scopus 로고
    • Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study
    • Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:2804-2810.
    • (2007) J Clin Oncol , vol.25 , pp. 2804-2810
    • Rose, P.G.1    Ali, S.2    Watkins, E.3
  • 48
    • 1542398694 scopus 로고    scopus 로고
    • Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG) 90-01
    • DOI 10.1200/JCO.2004.07.197
    • Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-880. (Pubitemid 41103599)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.5 , pp. 872-880
    • Eifel, P.J.1    Winter, K.2    Morris, M.3    Levenback, C.4    Grigsby, P.W.5    Cooper, J.6    Rotman, M.7    Gershenson, D.8    Mutch, D.G.9
  • 49
    • 35548963316 scopus 로고    scopus 로고
    • Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: Follow-up of a Gynecologic Oncology Group trial
    • Stehman FB, Ali S, Keys HM, et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007;197:1-6.
    • (2007) Am J Obstet Gynecol , vol.197 , pp. 1-6
    • Stehman, F.B.1    Ali, S.2    Keys, H.M.3
  • 50
    • 57449108492 scopus 로고    scopus 로고
    • Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials
    • Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
    • (2008) J Clin Oncol , vol.26 , pp. 5802-5812
  • 51
    • 34347209985 scopus 로고    scopus 로고
    • Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: Results of a population-based cohort study
    • Pearcey R, Miao Q, Kong W, et al. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study. J Clin Oncol 2007;25:2383-2388.
    • (2007) J Clin Oncol , vol.25 , pp. 2383-2388
    • Pearcey, R.1    Miao, Q.2    Kong, W.3
  • 52
    • 30344466113 scopus 로고    scopus 로고
    • Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects
    • DOI 10.1016/j.clon.2005.09.001, PII S0936655505003353
    • King M, McConkey C, Latief TN, et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006;18:38-45. (Pubitemid 43056695)
    • (2006) Clinical Oncology , vol.18 , Issue.1 , pp. 38-45
    • King, M.1    McConkey, C.2    Latief, T.N.3    Hartley, A.4    Fernando, I.5
  • 53
    • 43049176647 scopus 로고    scopus 로고
    • Long-term survival and late toxicity after chemoradiotherapy for cervical cancer - The Addenbrooke's experience
    • Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer - the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2008;20:358-364.
    • (2008) Clin Oncol (R Coll Radiol) , vol.20 , pp. 358-364
    • Tan, L.T.1    Zahra, M.2
  • 54
    • 34447508354 scopus 로고    scopus 로고
    • Multimodality therapy for locally advanced cervical carcinoma: State of the art and future directions
    • Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007;25:2952-2965.
    • (2007) J Clin Oncol , vol.25 , pp. 2952-2965
    • Monk, B.J.1    Tewari, K.S.2    Koh, W.J.3
  • 55
    • 56749122221 scopus 로고    scopus 로고
    • Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer
    • Cetina L, Garcia-Arias A, Uribe Mde J, et al. Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2008;29:608-612.
    • (2008) Eur J Gynaecol Oncol , vol.29 , pp. 608-612
    • Cetina, L.1    Garcia-Arias, A.2    Uribe, Mde.J.3
  • 56
    • 3242726144 scopus 로고    scopus 로고
    • Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer
    • Dubay RA, Rose PG, O'Malley DM, et al. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 2004;94:121-124.
    • (2004) Gynecol Oncol , vol.94 , pp. 121-124
    • Dubay, R.A.1    Rose, P.G.2    O'Malley, D.M.3
  • 57
    • 0038512533 scopus 로고    scopus 로고
    • Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer
    • Higgins RV, Naumann WR, Hall JB, Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 2003;89:499-503.
    • (2003) Gynecol Oncol , vol.89 , pp. 499-503
    • Higgins, R.V.1    Naumann, W.R.2    Hall, J.B.3    Haake, M.4
  • 58
    • 0037376123 scopus 로고    scopus 로고
    • Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial
    • Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1226-1232.
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , pp. 1226-1232
    • Lorvidhaya, V.1    Chitapanarux, I.2    Sangruchi, S.3
  • 59
    • 0033023214 scopus 로고    scopus 로고
    • Chemoradiation and adjuvant chemotherapy in cervical cancer
    • Wong LC, Ngan HY, Cheung AN, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999;17:2055-2060.
    • (1999) J Clin Oncol , vol.17 , pp. 2055-2060
    • Wong, L.C.1    Ngan, H.Y.2    Cheung, A.N.3
  • 60
    • 53449094789 scopus 로고    scopus 로고
    • Multimodality treatment in locoregional gynecological cancer: Cervical cancer treatment update
    • Poveda A, Gonzalez-Martin A. Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update. Ann Oncol 2008;19(Suppl 7):70-76.
    • (2008) Ann Oncol , vol.19 , Issue.SUPPL. 7 , pp. 70-76
    • Poveda, A.1    Gonzalez-Martin, A.2
  • 61
    • 68749120935 scopus 로고    scopus 로고
    • A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix
    • [abstract]. Abstract CRA5507
    • Duenas-Gonzalez A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix [abstract]. J Clin Oncol 2009;27(Suppl 1):Abstract CRA5507.
    • (2009) J Clin Oncol , vol.27 , Issue.SUPPL. 1
    • Duenas-Gonzalez, A.1    Zarba, J.J.2    Alcedo, J.C.3
  • 62
    • 1942540692 scopus 로고    scopus 로고
    • Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility
    • Koliopoulos G, Sotiriadis A, Kyrgiou M, et al. Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility. Gynecol Oncol 2004;93:469-473.
    • (2004) Gynecol Oncol , vol.93 , pp. 469-473
    • Koliopoulos, G.1    Sotiriadis, A.2    Kyrgiou, M.3
  • 63
    • 77649086842 scopus 로고    scopus 로고
    • Fertility-conserving surgery for young women with stage IA1 cervical cancer: Safety and access
    • Wright JD, NathavithArana R, Lewin SN, et al. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 2010;115:585-590.
    • (2010) Obstet Gynecol , vol.115 , pp. 585-590
    • Wright, J.D.1    NathavithArana, R.2    Lewin, S.N.3
  • 66
    • 20444434266 scopus 로고    scopus 로고
    • Vaginal radical trachelectomy: A valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature
    • Plante M, Renaud MC, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 2005;98:3-10.
    • (2005) Gynecol Oncol , vol.98 , pp. 3-10
    • Plante, M.1    Renaud, M.C.2    Hoskins, I.A.3    Roy, M.4
  • 67
    • 34250158771 scopus 로고    scopus 로고
    • Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): A comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH)
    • Marchiole P, Benchaib M, Buenerd A, et al. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 2007;106:132-141.
    • (2007) Gynecol Oncol , vol.106 , pp. 132-141
    • Marchiole, P.1    Benchaib, M.2    Buenerd, A.3
  • 68
    • 55649092023 scopus 로고    scopus 로고
    • Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma
    • Diaz JP, Sonoda Y, Leitao MM, et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol 2008;111:255-260.
    • (2008) Gynecol Oncol , vol.111 , pp. 255-260
    • Diaz, J.P.1    Sonoda, Y.2    Leitao, M.M.3
  • 69
    • 33646887965 scopus 로고    scopus 로고
    • Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women
    • Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG 2006;113:719-724.
    • (2006) BJOG , vol.113 , pp. 719-724
    • Shepherd, J.H.1    Spencer, C.2    Herod, J.3    Ind, T.E.4
  • 70
    • 34248344579 scopus 로고    scopus 로고
    • Ovarian metastases in early-stage cervical cancer (IA2-IIA): A multicenter retrospective study of 1965 patients (a Cooperative Task Force study)
    • Landoni F, Zanagnolo V, Lovato-Diaz L, et al. Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer 2007;17:623-628.
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 623-628
    • Landoni, F.1    Zanagnolo, V.2    Lovato-Diaz, L.3
  • 71
    • 33646421947 scopus 로고    scopus 로고
    • Ovarian metastasis in carcinoma of the uterine cervix
    • Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol 2006;101:234-237.
    • (2006) Gynecol Oncol , vol.101 , pp. 234-237
    • Shimada, M.1    Kigawa, J.2    Nishimura, R.3
  • 72
    • 76349090960 scopus 로고    scopus 로고
    • Impact of sentinel lymph node biopsy on staging of early cervical cancer: Results of a prospective, multicenter study
    • [abstract]. Abstract CRA5506
    • Lecuru F, Bats A, Mathevet P, et al. Impact of sentinel lymph node biopsy on staging of early cervical cancer: Results of a prospective, multicenter study [abstract]. J Clin Oncol 2009;27(Suppl 18):Abstract CRA5506.
    • (2009) J Clin Oncol , vol.27 , Issue.SUPPL. 18
    • Lecuru, F.1    Bats, A.2    Mathevet, P.3
  • 73
    • 46449113315 scopus 로고    scopus 로고
    • Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group
    • Altgassen C, Hertel H, Brandstadt A, et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008;26:2943-2951.
    • (2008) J Clin Oncol , vol.26 , pp. 2943-2951
    • Altgassen, C.1    Hertel, H.2    Brandstadt, A.3
  • 74
    • 52249116069 scopus 로고    scopus 로고
    • Sentinel lymph node biopsy in early-stage cervical cancer: Utility of intraoperative versus postoperative assessment
    • Fader AN, Edwards RP, Cost M, et al. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol 2008;111:13-17.
    • (2008) Gynecol Oncol , vol.111 , pp. 13-17
    • Fader, A.N.1    Edwards, R.P.2    Cost, M.3
  • 75
    • 41649110218 scopus 로고    scopus 로고
    • Diagnostic accuracy of tests for lymph node status in primary cervical cancer: A systematic review and meta-analysis
    • Selman TJ, Mann C, Zamora J, et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008;178:855-862.
    • (2008) CMAJ , vol.178 , pp. 855-862
    • Selman, T.J.1    Mann, C.2    Zamora, J.3
  • 76
    • 34548118367 scopus 로고    scopus 로고
    • Sentinel lymph node detection in early stage uterine cervix carcinoma: A systematic review
    • van de Lande J, Torrenga B, Raijmakers PG, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 2007;106:604-613.
    • (2007) Gynecol Oncol , vol.106 , pp. 604-613
    • Van De Lande, J.1    Torrenga, B.2    Raijmakers, P.G.3
  • 77
    • 34848916687 scopus 로고    scopus 로고
    • The sentinel concept in patients with cervical cancer
    • DOI 10.1002/jso.20864
    • Schneider A. The sentinel concept in patients with cervical cancer. J Surg Oncol 2007;96:337-341. (Pubitemid 47509769)
    • (2007) Journal of Surgical Oncology , vol.96 , Issue.4 , pp. 337-341
    • Schneider, A.1
  • 78
    • 77949305923 scopus 로고    scopus 로고
    • Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy
    • Pandit-Taskar N, Gemignani ML, Lyall A, et al. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 2010;117:59-64.
    • (2010) Gynecol Oncol , vol.117 , pp. 59-64
    • Pandit-Taskar, N.1    Gemignani, M.L.2    Lyall, A.3
  • 79
    • 0032871547 scopus 로고    scopus 로고
    • Impact of surgical staging in women with locally advanced cervical cancer
    • Goff BA, Muntz HG, Paley PJ, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436-442.
    • (1999) Gynecol Oncol , vol.74 , pp. 436-442
    • Goff, B.A.1    Muntz, H.G.2    Paley, P.J.3
  • 80
    • 13844299304 scopus 로고    scopus 로고
    • Rethinking the use of radiation and chemotherapy after radical hysterectomy: A clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial
    • Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005;96:721-728.
    • (2005) Gynecol Oncol , vol.96 , pp. 721-728
    • Monk, B.J.1    Wang, J.2    Im, S.3
  • 81
    • 30544451903 scopus 로고    scopus 로고
    • Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix
    • Chernofsky MR, Felix JC, Muderspach LI, et al. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol 2006;100:288-293.
    • (2006) Gynecol Oncol , vol.100 , pp. 288-293
    • Chernofsky, M.R.1    Felix, J.C.2    Muderspach, L.I.3
  • 82
    • 20444477414 scopus 로고    scopus 로고
    • Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: A retrospective case-control surgico-pathological study
    • Marchiole P, Buenerd A, Benchaib M, et al. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 2005;97:727-732.
    • (2005) Gynecol Oncol , vol.97 , pp. 727-732
    • Marchiole, P.1    Buenerd, A.2    Benchaib, M.3
  • 83
    • 0032907420 scopus 로고    scopus 로고
    • A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study
    • Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 1999;73:177-183.
    • (1999) Gynecol Oncol , vol.73 , pp. 177-183
    • Sedlis, A.1    Bundy, B.N.2    Rotman, M.Z.3
  • 84
    • 33646471880 scopus 로고    scopus 로고
    • A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study
    • Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006;65:169-176.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 169-176
    • Rotman, M.1    Sedlis, A.2    Piedmonte, M.R.3
  • 85
    • 0033838518 scopus 로고    scopus 로고
    • Posttherapy surveillance of women with cervical cancer: An outcomes analysis
    • Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 2000;78:187-193.
    • (2000) Gynecol Oncol , vol.78 , pp. 187-193
    • Bodurka-Bevers, D.1    Morris, M.2    Eifel, P.J.3
  • 86
    • 10744228385 scopus 로고    scopus 로고
    • Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy
    • Morice P, Deyrolle C, Rey A, et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann Oncol 2004;15:218-223.
    • (2004) Ann Oncol , vol.15 , pp. 218-223
    • Morice, P.1    Deyrolle, C.2    Rey, A.3
  • 87
    • 67651147948 scopus 로고    scopus 로고
    • Follow-up for women after treatment for cervical cancer: A systematic review
    • Elit L, Fyles AW, Devries MC, et al. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 2009;114:528-535.
    • (2009) Gynecol Oncol , vol.114 , pp. 528-535
    • Elit, L.1    Fyles, A.W.2    Devries, M.C.3
  • 88
    • 57649108540 scopus 로고    scopus 로고
    • Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer
    • Brooks RA, Rader JS, Dehdashti F, et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol 2009;112:104-109.
    • (2009) Gynecol Oncol , vol.112 , pp. 104-109
    • Brooks, R.A.1    Rader, J.S.2    Dehdashti, F.3
  • 89
    • 36349035495 scopus 로고    scopus 로고
    • Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma
    • Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007;298:2289-2295.
    • (2007) JAMA , vol.298 , pp. 2289-2295
    • Schwarz, J.K.1    Siegel, B.A.2    Dehdashti, F.3    Grigsby, P.W.4
  • 90
    • 33947224027 scopus 로고    scopus 로고
    • Post-therapy surveillance of patients with uterine cancers: Value of integrated FDG PET/ CT in the detection of recurrence
    • Sironi S, Picchio M, Landoni C, et al. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/ CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 2007;34:472-479.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 472-479
    • Sironi, S.1    Picchio, M.2    Landoni, C.3
  • 91
    • 65649134344 scopus 로고    scopus 로고
    • Surveillance procedures for patients with cervical carcinoma: A review of the literature
    • Zanagnolo V, Ming L, Gadducci A, et al. Surveillance procedures for patients with cervical carcinoma: a review of the literature. Int J Gynecol Cancer 2009;19:194-201.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 194-201
    • Zanagnolo, V.1    Ming, L.2    Gadducci, A.3
  • 92
    • 33846934486 scopus 로고    scopus 로고
    • Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence
    • Chung HH, Jo H, Kang WJ, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 2007;104:529-534.
    • (2007) Gynecol Oncol , vol.104 , pp. 529-534
    • Chung, H.H.1    Jo, H.2    Kang, W.J.3
  • 93
    • 60949107393 scopus 로고    scopus 로고
    • Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
    • Chaturvedi AK, Kleinerman RA, Hildesheim A, et al. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol 2009;27:967-973.
    • (2009) J Clin Oncol , vol.27 , pp. 967-973
    • Chaturvedi, A.K.1    Kleinerman, R.A.2    Hildesheim, A.3
  • 94
    • 36048985799 scopus 로고    scopus 로고
    • Second cancers among 104,760 survivors of cervical cancer: Evaluation of longterm risk
    • Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of longterm risk. J Natl Cancer Inst 2007;99:1634-1643.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1634-1643
    • Chaturvedi, A.K.1    Engels, E.A.2    Gilbert, E.S.3
  • 95
    • 60549091045 scopus 로고    scopus 로고
    • Radiation-associated endometrial cancer
    • Kumar S, Shah JP, Bryant CS, et al. Radiation-associated endometrial cancer. Obstet Gynecol 2009;113:319-325.
    • (2009) Obstet Gynecol , vol.113 , pp. 319-325
    • Kumar, S.1    Shah, J.P.2    Bryant, C.S.3
  • 96
    • 0027432645 scopus 로고
    • Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery
    • Thomas GM, Dembo AJ, Myhr T, et al. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 1993;3:193-198.
    • (1993) Int J Gynecol Cancer , vol.3 , pp. 193-198
    • Thomas, G.M.1    Dembo, A.J.2    Myhr, T.3
  • 97
    • 0037376118 scopus 로고    scopus 로고
    • Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix
    • Kim JS, Kim SY, Kim KH, Cho MJ. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2003;55:1247-1253.
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , pp. 1247-1253
    • Kim, J.S.1    Kim, S.Y.2    Kim, K.H.3    Cho, M.J.4
  • 98
    • 20144379256 scopus 로고    scopus 로고
    • Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: A phase I/II study
    • Chung YL, Jian JJ, Cheng SH, et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecol Oncol 2005;97:126-135.
    • (2005) Gynecol Oncol , vol.97 , pp. 126-135
    • Chung, Y.L.1    Jian, J.J.2    Cheng, S.H.3
  • 99
    • 25144459382 scopus 로고    scopus 로고
    • Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA
    • Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 2005;99:153-159.
    • (2005) Gynecol Oncol , vol.99 , pp. 153-159
    • Berek, J.S.1    Howe, C.2    Lagasse, L.D.3    Hacker, N.F.4
  • 100
    • 33646409577 scopus 로고    scopus 로고
    • Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
    • Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 2006;101:261-268.
    • (2006) Gynecol Oncol , vol.101 , pp. 261-268
    • Goldberg, G.L.1    Sukumvanich, P.2    Einstein, M.H.3
  • 102
    • 34248232123 scopus 로고    scopus 로고
    • Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers
    • Fleisch MC, Pantke P, Beckmann MW, et al. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J Surg Oncol 2007;95:476-484.
    • (2007) J Surg Oncol , vol.95 , pp. 476-484
    • Fleisch, M.C.1    Pantke, P.2    Beckmann, M.W.3
  • 103
    • 34548505779 scopus 로고    scopus 로고
    • Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies
    • Tran PT, Su Z, Hara W, et al. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys 2007;69:504-511.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , pp. 504-511
    • Tran, P.T.1    Su, Z.2    Hara, W.3
  • 105
    • 0016698823 scopus 로고
    • Exenterative operations: Experience with 198 patients
    • Symmonds RE, Pratt JH, Webb MJ. Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 1975;121:907-918.
    • (1975) Am J Obstet Gynecol , vol.121 , pp. 907-918
    • Symmonds, R.E.1    Pratt, J.H.2    Webb, M.J.3
  • 106
    • 33846849527 scopus 로고    scopus 로고
    • Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: Flap-specific morbidity
    • Soper JT, Secord AA, Havrilesky LJ, et al. Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity. Int J Gynecol Cancer 2007;17:298-303.
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 298-303
    • Soper, J.T.1    Secord, A.A.2    Havrilesky, L.J.3
  • 107
    • 0036924207 scopus 로고    scopus 로고
    • Vaginal reconstruction at the time of pelvic exenteration: A surgical and psychosexual analysis of techniques
    • Mirhashemi R, Averette HE, Lambrou N, et al. Vaginal reconstruction at the time of pelvic exenteration: a surgical and psychosexual analysis of techniques. Gynecol Oncol 2002;87:39-45.
    • (2002) Gynecol Oncol , vol.87 , pp. 39-45
    • Mirhashemi, R.1    Averette, H.E.2    Lambrou, N.3
  • 108
    • 0035083580 scopus 로고    scopus 로고
    • Psychosocial issues: Pelvic exenterative surgery
    • Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 2001;76:224-236.
    • (2001) J Surg Oncol , vol.76 , pp. 224-236
    • Turns, D.1
  • 109
    • 0027400980 scopus 로고
    • Effect of rest interval on tumor and normal tissue response - A report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502)
    • Spanos WJ Jr, Perez CA, Marcus S, et al. Effect of rest interval on tumor and normal tissue response - a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502). Int J Radiat Oncol Biol Phys 1993;25:399-403.
    • (1993) Int J Radiat Oncol Biol Phys , vol.25 , pp. 399-403
    • Spanos Jr., W.J.1    Perez, C.A.2    Marcus, S.3
  • 110
    • 34247178416 scopus 로고    scopus 로고
    • A review of hypofractionated palliative radiotherapy
    • Lutz ST, Chow EL, Hartsell WF, Konski AA. A review of hypofractionated palliative radiotherapy. Cancer 2007;109:1462-1470.
    • (2007) Cancer , vol.109 , pp. 1462-1470
    • Lutz, S.T.1    Chow, E.L.2    Hartsell, W.F.3    Konski, A.A.4
  • 111
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    • Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2004;22:3113-3119.
    • (2004) J Clin Oncol , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3
  • 112
    • 23044495279 scopus 로고    scopus 로고
    • Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
    • Long HJ III, Bundy BN, Grendys EC Jr, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 2005;23:4626-4633.
    • (2005) J Clin Oncol , vol.23 , pp. 4626-4633
    • Long III, H.J.1    Bundy, B.N.2    Grendys Jr., E.C.3
  • 113
    • 0019408691 scopus 로고
    • Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    • DOI 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0. CO;2-6
    • Thigpen T, Shingleton H, Homesley H, et al. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981;48:899-903. (Pubitemid 11049085)
    • (1981) Cancer , vol.48 , Issue.4 , pp. 899-903
    • Thigpen, T.1    Shingleton, H.2    Homesley, H.3
  • 114
    • 38949132628 scopus 로고    scopus 로고
    • Chemotherapy for advanced, recurrent, and metastatic cervical cancer
    • Moore DH. Chemotherapy for advanced, recurrent, and metastatic cervical cancer. J Natl Compr Canc Netw 2008;6:53-57.
    • (2008) J Natl Compr Canc Netw , vol.6 , pp. 53-57
    • Moore, D.H.1
  • 115
    • 50049105426 scopus 로고    scopus 로고
    • Chemotherapy for recurrent and metastatic cervical cancer
    • Tao X, Hu W, Ramirez PT, Kavanagh JJ. Chemotherapy for recurrent and metastatic cervical cancer. Gynecol Oncol 2008;110:67-71.
    • (2008) Gynecol Oncol , vol.110 , pp. 67-71
    • Tao, X.1    Hu, W.2    Ramirez, P.T.3    Kavanagh, J.J.4
  • 116
    • 70350433286 scopus 로고    scopus 로고
    • Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: A Gynecologic Oncology Group study
    • Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009;27:4649-4655.
    • (2009) J Clin Oncol , vol.27 , pp. 4649-4655
    • Monk, B.J.1    Sill, M.W.2    McMeekin, D.S.3
  • 117
    • 34247156192 scopus 로고    scopus 로고
    • A comparison of cisplatin/ paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
    • Moore KN, Herzog TJ, Lewin S, et al. A comparison of cisplatin/ paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol 2007;105:299-303.
    • (2007) Gynecol Oncol , vol.105 , pp. 299-303
    • Moore, K.N.1    Herzog, T.J.2    Lewin, S.3
  • 118
    • 20444442671 scopus 로고    scopus 로고
    • Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: The British Columbia Cancer Agency experience
    • Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. Gynecol Oncol 2005;98:54-58.
    • (2005) Gynecol Oncol , vol.98 , pp. 54-58
    • Tinker, A.V.1    Bhagat, K.2    Swenerton, K.D.3    Hoskins, P.J.4
  • 119
    • 67651055446 scopus 로고    scopus 로고
    • Carboplatin and paclitaxel in metastatic or recurrent cervical cancer
    • Pectasides D, Fountzilas G, Papaxoinis G, et al. Carboplatin and paclitaxel in metastatic or recurrent cervical cancer. Int J Gynecol Cancer 2009;19:777-781.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 777-781
    • Pectasides, D.1    Fountzilas, G.2    Papaxoinis, G.3
  • 120
    • 74949119951 scopus 로고    scopus 로고
    • A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
    • Saito I, Kitagawa R, Fukuda H, et al. A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505). Jpn J Clin Oncol 2010;40:90-93.
    • (2010) Jpn J Clin Oncol , vol.40 , pp. 90-93
    • Saito, I.1    Kitagawa, R.2    Fukuda, H.3
  • 121
    • 62949142263 scopus 로고    scopus 로고
    • Recent achievements and future developments in advanced and recurrent cervical cancer: Trials of the Gynecologic Oncology Group
    • Tewari KS, Monk BJ. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group. Semin Oncol 2009;36:170-180.
    • (2009) Semin Oncol , vol.36 , pp. 170-180
    • Tewari, K.S.1    Monk, B.J.2
  • 122
    • 0024561232 scopus 로고
    • A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study
    • Thigpen JT, Blessing JA, DiSaia PJ, et al. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989;32:198-202.
    • (1989) Gynecol Oncol , vol.32 , pp. 198-202
    • Thigpen, J.T.1    Blessing, J.A.2    DiSaia, P.J.3
  • 124
    • 0024350119 scopus 로고
    • A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: A Gynecologic Oncology Group study
    • McGuire WP, Arseneau J, Blessing JA, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989;7:1462-1468.
    • (1989) J Clin Oncol , vol.7 , pp. 1462-1468
    • McGuire, W.P.1    Arseneau, J.2    Blessing, J.A.3
  • 125
    • 0025635642 scopus 로고
    • A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: A Southwest Oncology Group study
    • Weiss GR, Green S, Hannigan EV, et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecol Oncol 1990;39:332-336.
    • (1990) Gynecol Oncol , vol.39 , pp. 332-336
    • Weiss, G.R.1    Green, S.2    Hannigan, E.V.3
  • 126
    • 9844223395 scopus 로고    scopus 로고
    • An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix
    • Kudelka AP, Winn R, Edwards CL, et al. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 1997;8:657-661.
    • (1997) Anticancer Drugs , vol.8 , pp. 657-661
    • Kudelka, A.P.1    Winn, R.2    Edwards, C.L.3
  • 127
    • 0029865737 scopus 로고    scopus 로고
    • Paclitaxel has moderate activity in squamous cervix cancer
    • A Gynecologic Oncology Group study
    • McGuire WP, Blessing JA, Moore D, et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 1996;14:792-795.
    • (1996) J Clin Oncol , vol.14 , pp. 792-795
    • McGuire, W.P.1    Blessing, J.A.2    Moore, D.3
  • 128
    • 61549141361 scopus 로고    scopus 로고
    • Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Monk BJ, Sill MW, Burger RA, et al. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2009;27:1069-1074.
    • (2009) J Clin Oncol , vol.27 , pp. 1069-1074
    • Monk, B.J.1    Sill, M.W.2    Burger, R.A.3
  • 129
    • 34548437625 scopus 로고    scopus 로고
    • Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    • Garcia AA, Blessing JA, Vaccarello L, Roman LD. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Clin Oncol 2007;30:428-431.
    • (2007) Am J Clin Oncol , vol.30 , pp. 428-431
    • Garcia, A.A.1    Blessing, J.A.2    Vaccarello, L.3    Roman, L.D.4
  • 130
    • 0029836259 scopus 로고    scopus 로고
    • A phase II trial of 5-fluorouracil and high-dose leucovorin in patients with recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    • Look KY, Blessing JA, Gallup DG, Lentz SS. A phase II trial of 5-fluorouracil and high-dose leucovorin in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Clin Oncol 1996;19:439-441.
    • (1996) Am J Clin Oncol , vol.19 , pp. 439-441
    • Look, K.Y.1    Blessing, J.A.2    Gallup, D.G.3    Lentz, S.S.4
  • 131
    • 10044252050 scopus 로고    scopus 로고
    • Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
    • Schilder RJ, Blessing J, Cohn DE. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2005;96:103-107.
    • (2005) Gynecol Oncol , vol.96 , pp. 103-107
    • Schilder, R.J.1    Blessing, J.2    Cohn, D.E.3
  • 132
    • 0022871494 scopus 로고
    • A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix
    • Coleman RE, Harper PG, Gallagher C, et al. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1986;18:280-283.
    • (1986) Cancer Chemother Pharmacol , vol.18 , pp. 280-283
    • Coleman, R.E.1    Harper, P.G.2    Gallagher, C.3
  • 133
    • 0027394743 scopus 로고
    • Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study
    • Sutton GP, Blessing JA, McGuire WP, et al. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1993;168:805-807.
    • (1993) Am J Obstet Gynecol , vol.168 , pp. 805-807
    • Sutton, G.P.1    Blessing, J.A.2    McGuire, W.P.3
  • 135
    • 0034891891 scopus 로고    scopus 로고
    • Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix
    • A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study
    • Wagenaar HC, Pecorelli S, Mangioni C, et al. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study. Eur J Cancer 2001;37:1624-1628.
    • (2001) Eur J Cancer , vol.37 , pp. 1624-1628
    • Wagenaar, H.C.1    Pecorelli, S.2    Mangioni, C.3
  • 136
    • 0034089496 scopus 로고    scopus 로고
    • Topotecan in squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
    • Bookman MA, Blessing JA, Hanjani P, et al. Topotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2000;77:446-449.
    • (2000) Gynecol Oncol , vol.77 , pp. 446-449
    • Bookman, M.A.1    Blessing, J.A.2    Hanjani, P.3
  • 137
    • 0035025316 scopus 로고    scopus 로고
    • A phase II study of topotecan in patients with squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study
    • DOI 10.1006/gyno.2000.6024
    • Muderspach LI, Blessing JA, Levenback C, Moore JL. A phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 2001;81:213-215. (Pubitemid 32424163)
    • (2001) Gynecologic Oncology , vol.81 , Issue.2 , pp. 213-215
    • Muderspach, L.I.1    Blessing, J.A.2    Levenback, C.3    Moore Jr., J.L.4
  • 138
    • 45549084543 scopus 로고    scopus 로고
    • Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
    • Miller DS, Blessing JA, Bodurka DC, et al. Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2008;110:65-70.
    • (2008) Gynecol Oncol , vol.110 , pp. 65-70
    • Miller, D.S.1    Blessing, J.A.2    Bodurka, D.C.3
  • 139
    • 0842310543 scopus 로고    scopus 로고
    • Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    • Muggia FM, Blessing JA, Method M, et al. Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:639-643.
    • (2004) Gynecol Oncol , vol.92 , pp. 639-643
    • Muggia, F.M.1    Blessing, J.A.2    Method, M.3
  • 140
    • 50649085243 scopus 로고    scopus 로고
    • Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
    • Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574-580.
    • (2008) J Allergy Clin Immunol , vol.122 , pp. 574-580
    • Castells, M.C.1    Tennant, N.M.2    Sloane, D.E.3
  • 141
    • 33645004715 scopus 로고    scopus 로고
    • Second symposium on the definition and management of anaphylaxis: Summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
    • Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006;47:373-380.
    • (2006) Ann Emerg Med , vol.47 , pp. 373-380
    • Sampson, H.A.1    Munoz-Furlong, A.2    Campbell, R.L.3
  • 142
    • 68249119237 scopus 로고    scopus 로고
    • Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis
    • Manivannan V, Decker WW, Stead LG, et al. Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis. Int J Emerg Med 2009;2:3-5.
    • (2009) Int J Emerg Med , vol.2 , pp. 3-5
    • Manivannan, V.1    Decker, W.W.2    Stead, L.G.3
  • 143
    • 35548983383 scopus 로고    scopus 로고
    • Management and preparedness for infusion and hypersensitivity reactions
    • Lenz HJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007;12:601-609.
    • (2007) Oncologist , vol.12 , pp. 601-609
    • Lenz, H.J.1
  • 144
    • 1542438610 scopus 로고    scopus 로고
    • Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity
    • Markman M, Zanotti K, Peterson G, et al. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003;21:4611-4614.
    • (2003) J Clin Oncol , vol.21 , pp. 4611-4614
    • Markman, M.1    Zanotti, K.2    Peterson, G.3
  • 145
    • 27144464530 scopus 로고    scopus 로고
    • Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses
    • Lee CW, Matulonis UA, Castells MC. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 2005;99:393-399.
    • (2005) Gynecol Oncol , vol.99 , pp. 393-399
    • Lee, C.W.1    Matulonis, U.A.2    Castells, M.C.3
  • 146
    • 7444222347 scopus 로고    scopus 로고
    • Carboplatin hypersensitivity: A 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions
    • Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004;95:370-376.
    • (2004) Gynecol Oncol , vol.95 , pp. 370-376
    • Lee, C.W.1    Matulonis, U.A.2    Castells, M.C.3
  • 148
    • 42149123438 scopus 로고    scopus 로고
    • Therapeutic human papillomavirus vaccines: Current clinical trials and future directions
    • Hung C-F, Ma B, Monie A, et al. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther 2008;8:421-439.
    • (2008) Expert Opin Biol Ther , vol.8 , pp. 421-439
    • Hung, C.-F.1    Ma, B.2    Monie, A.3
  • 151
    • 34848922746 scopus 로고    scopus 로고
    • Molecular biology of cervical cancer
    • Gonzalez Martin A. Molecular biology of cervical cancer. Clin Transl Oncol 2007;9:347-354.
    • (2007) Clin Transl Oncol , vol.9 , pp. 347-354
    • Gonzalez Martin, A.1
  • 152
    • 78951475689 scopus 로고    scopus 로고
    • Biologic and physical aspects of radiation oncology
    • Barakat R, Markman M, Randall M, eds. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins;
    • Erickson-Whitmann B, Rownd J, Khater K. Biologic and physical aspects of radiation oncology. In: Barakat R, Markman M, Randall M, eds. Principles and Practice of Gynecology Oncology, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:325-380.
    • (2009) Principles and Practice of Gynecology Oncology , pp. 325-380
    • Erickson-Whitmann, B.1    Rownd, J.2    Khater, K.3
  • 153
    • 34247156162 scopus 로고    scopus 로고
    • Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer
    • Beriwal S, Gan GN, Heron DE, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007;68:166-171.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 166-171
    • Beriwal, S.1    Gan, G.N.2    Heron, D.E.3
  • 154
    • 33947524585 scopus 로고    scopus 로고
    • Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: Comparison with conventional radiotherapy
    • Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1438-1444.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 1438-1444
    • Chen, M.F.1    Tseng, C.J.2    Tseng, C.C.3
  • 155
    • 52649089690 scopus 로고    scopus 로고
    • Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients
    • Chen MF, Tseng CJ, Tseng CC, et al. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J 2008;14:200-206.
    • (2008) Cancer J , vol.14 , pp. 200-206
    • Chen, M.F.1    Tseng, C.J.2    Tseng, C.C.3
  • 156
    • 33745198205 scopus 로고    scopus 로고
    • Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies
    • Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006;65:1170-1176.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , pp. 1170-1176
    • Salama, J.K.1    Mundt, A.J.2    Roeske, J.3    Mehta, N.4
  • 157
    • 43049174720 scopus 로고    scopus 로고
    • Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer
    • Small W, Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:428-434.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , pp. 428-434
    • Small, W.1    Mell, L.K.2    Anderson, P.3
  • 158
    • 0026676867 scopus 로고
    • The effect of treatment duration in the local control of cervix cancer
    • Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-279.
    • (1992) Radiother Oncol , vol.25 , pp. 273-279
    • Fyles, A.1    Keane, T.J.2    Barton, M.3    Simm, J.4
  • 159
    • 0027333498 scopus 로고
    • Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome
    • Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051-1056.
    • (1993) Int J Radiat Oncol Biol Phys , vol.27 , pp. 1051-1056
    • Girinsky, T.1    Rey, A.2    Roche, B.3
  • 160
    • 0027457109 scopus 로고
    • The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study
    • Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25:391-397.
    • (1993) Int J Radiat Oncol Biol Phys , vol.25 , pp. 391-397
    • Lanciano, R.M.1    Pajak, T.F.2    Martz, K.3    Hanks, G.E.4
  • 161
    • 0029099034 scopus 로고
    • Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy
    • Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-1288.
    • (1995) Int J Radiat Oncol Biol Phys , vol.32 , pp. 1275-1288
    • Perez, C.A.1    Grigsby, P.W.2    Castro-Vita, H.3    Lockett, M.A.4
  • 162
  • 163
    • 0007612189 scopus 로고    scopus 로고
    • Cancer in the pregnant patient
    • Hoskins WJ, Perez CA, Young RC, eds. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins;
    • Swenson RE, Goff BA, Koh WJ, et al. Cancer in the pregnant patient. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1279-1311.
    • (2004) Principles and Practice of Gynecologic Oncology , pp. 1279-1311
    • Swenson, R.E.1    Goff, B.A.2    Koh, W.J.3
  • 165
    • 16544369052 scopus 로고    scopus 로고
    • Conservative treatment of stage IA2 squamous cell carcinoma of the cervix during pregnancy
    • Ben-Arie A, Levy R, Lavie O, et al. Conservative treatment of stage IA2 squamous cell carcinoma of the cervix during pregnancy. Obstet Gynecol 2004;104:1129-1131.
    • (2004) Obstet Gynecol , vol.104 , pp. 1129-1131
    • Ben-Arie, A.1    Levy, R.2    Lavie, O.3
  • 166
    • 70749154834 scopus 로고    scopus 로고
    • Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation
    • Abu-Rustum NR, Tal MN, DeLair D, et al. Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation. Gynecol Oncol 2010;116:151-152.
    • (2010) Gynecol Oncol , vol.116 , pp. 151-152
    • Abu-Rustum, N.R.1    Tal, M.N.2    DeLair, D.3
  • 167
    • 70349332461 scopus 로고    scopus 로고
    • Postpartum radical trachelectomy for IB1 squamous cell carcinoma of the cervix diagnosed in pregnancy
    • Gurney EP, Blank SV. Postpartum radical trachelectomy for IB1 squamous cell carcinoma of the cervix diagnosed in pregnancy. Am J Obstet Gynecol 2009;201:e8-10.
    • (2009) Am J Obstet Gynecol , vol.201
    • Gurney, E.P.1    Blank, S.V.2
  • 168
    • 34447526800 scopus 로고    scopus 로고
    • Impact of the human papilloma vaccine on cervical cancer
    • Chan JK, Berek JS. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol 2007;25:2975-2982.
    • (2007) J Clin Oncol , vol.25 , pp. 2975-2982
    • Chan, J.K.1    Berek, J.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.